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: ECM optimization. PTECs are seeded on engineered ECMs composed of 10 mg/ml fibrin and varying gelatin concentration. The PTEC media used for all culture conditions is serum-free. PTECs adhere to and proliferate better on ECMs with a gelatin concentration of £ 1%. [Note: The final fibrin concentration is increased to 25 mg/ml to match the elastic modulus (~4 kPa) found in native kidney cortex tissues (Fig. S2B ). This change did not alter the cell viability or proliferation.] Scale bar = 50 µm. (1), we determined the effective permeability of PTEC and GMEC barriers from the captured image time-series. Compared to the channels that are lined with PTECs and GMECs, the empty 3D PT (without cells, control) exhibits a much higher diffusional permeability, i.e., FITC-labeled inulin diffuses much faster into the surrounding ECM in the control. The measured permeability values of the PTEC-and GMEC-lined channels are consistent with values reported previously in (1, 4) . Notably, the measured permeability of our endothelial-lined channel is ~0.6X10 -5 cm/s (70kDa dextran), which is roughly five-fold higher than the reported in vivo value (5) of ~ 0.15X10 -5 cm/s. In addition, we find that the permeability roughly decreases with increasing molecular weight, consistent with in vivo measurements (5) . Scale bar = 500µm; error bars represent standard deviation of the mean, * p < 0.05; ***p<0.0001.
Figure S8: Gene expression analysis.
We performed qPCR to quantify mRNA levels of (A) AQP1, (B) NCAD, (C) SGLTs, (D) Ki67, (E) Na + /K + ATPase, and (F) ZO1 in our 3D VasPT models in the absence and presence of GMEC co-culture. We observed upregulation of (A) water channel, aquaporin 1 (AQP1), (B) N-Cadherin (CDH2) and (C) glucose transporter (SGLT2), in PTEC-GMEC coculture conditions. (D) We also find that Ki67, a proliferation marker, is downregulated in PTEC-GMEC co-culture, potentially indicative of a higher PTEC maturity. We did not find significant changes in other genes tested, i.e., (E) Na + /K + ATPase and (F) ZO1. As shown in (C), the glucose transporter SGLT1 was not detected in either mono or co-culture conditions. The SGLT1 value is normalized by the SGLT2 (monoculture) value. Error bars represent standard deviation of the mean, n = 3; N.S., not significant; * p < 0.05; ** p < 0.001.
Figure S9: Direct imaging of albumin reabsorption and vectorial transport. (A)
After perfusing Cy5-labeled human serum albumin (HSA-Cy5) through the PT channel for 12 h, HSA-Cy5 is reabsorbed by PTECs and transported to the surrounding ECM and adjacent vascular channel. The HSA-Cy5 concentration in the PT perfusate is significantly lower than that measured for the vascular perfusate. (B) Three acellular chips with different channel separations, which highlight the HSA-Cy5 concentration gradient that evolves between the PT and vascular channels. (C) The slope of the measured HSA-Cy5 concentration gradient between these channels is roughly inversely proportional to their channel separation (gray line). Overall, these data suggest that the "cross-talk" between the PT and vascular channels is enhanced by their closer proximity to one another. Error bars represent standard deviation of the mean. Figure S11 : VEGF uptake in GMECs determined using ELISA. The amount of VEGF uptake is calculated by subtracting the measured final VEGF concentration from its initial value of 2000 pg/ml. The uptake of VEGF is elevated under hyperglycemic conditions. However, the VEGF uptake is reduced to the value observed for the normal (control) sample when dapagliflozin is administered. Error bars represent standard deviation of the mean, N.S., not significant; * p < 0.05. [Note: The normal (control) sample corresponds to a 3D VasPT tissue exposed to 100 mg glucose/dL delivered through the PT lumen, whereas hyperglycemic samples correspond to 3D VasPT tissues exposed to 400 mg glucose/dL in the absence and presence of dapagliflozin.] The normal (control) sample corresponds to a 3D VasPT tissue exposed to 100 mg glucose/dL delivered through the PT lumen, whereas hyperglycemic samples correspond to 3D VasPT tissues exposed to 400 mg glucose/dL in the absence and presence of dapagliflozin.] Movie S1: Fabrication of a convoluted 3D vascularized proximal tubule model via bioprinting.
